Why in news?
Keralam (formerly Kerala) Chief Minister V. D. Satheesan's criticism of unnecessary angioplasty has prompted objections from medical organisations. The debate was reported earlier in October and examined in a Hindu opinion article on 28 October 2026. Coronary angioplasty opens narrowed or blocked arteries supplying the heart, often with a small mesh support called a stent. The disagreement concerns whether some patients receive procedures without sufficient benefit, and whether broad criticism could undermine confidence in necessary care. The crucial clinical distinction is between urgent treatment for an acute coronary problem and planned treatment for stable disease. Research supports different decisions in these situations. The controversy calls for evidence about individual treatment decisions. It does not establish that all stents are unnecessary or that statewide overuse has been measured.
What the procedure changes inside an artery
The heart muscle receives oxygen through coronary arteries. Atherosclerosis involves plaque building up within their walls, potentially narrowing the channel available for blood flow. Angioplasty is part of percutaneous coronary intervention, usually shortened to PCI. Percutaneous means access through the skin, rather than opening the chest for bypass surgery. A specialist uses a catheter, a thin flexible tube, to reach the affected artery. A balloon can widen the narrowed segment, and a stent can help keep that segment open.
An angiogram is different: it is an imaging examination showing the coronary arteries and their narrowings. Angiography can help plan treatment, while angioplasty is an intervention. A visible narrowing supplies information about anatomy, but the clinical decision also involves symptoms, blood-flow effects and the overall pattern of disease. The percentage narrowing cannot answer every question about expected benefit. This is why detecting a blockage and deciding how to treat a patient are connected but separate tasks.
Why an acute coronary problem needs urgent assessment
Acute coronary syndrome describes conditions involving a sudden reduction in blood flow to heart muscle, including heart attacks and unstable angina. Angina is discomfort associated with inadequate oxygen supply to the heart. An unstable plaque can rupture or erode, allowing a clot to form and obstruct flow. The 2025 American College of Cardiology and American Heart Association guideline treats these acute conditions as a distinct clinical setting. In appropriate patients, restoring blood flow promptly is central to care.
The guideline recommends emergency restoration of blood supply when an acute coronary syndrome causes shock or instability. Shock here means that the heart cannot pump enough blood to meet the body's needs. Other acute presentations also require assessment and treatment according to their risk. A general debate about unnecessary procedures should not become a reason to postpone emergency evaluation. A person cannot safely classify new or worsening chest symptoms as stable disease merely because the discomfort seems mild.
What the stable-disease trial actually compared
The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches is known as ISCHEMIA. Its main findings appeared in 2020. Researchers randomly assigned 5,179 patients with stable coronary disease and moderate or severe ischaemia, meaning inadequate blood supply. One strategy began with angiography and PCI or bypass surgery when feasible, alongside medical treatment. The other began with medical treatment and reserved angiography for failure of that approach.
Over a median follow-up of 3.2 years, the trial did not establish a reduction in its main combined cardiovascular outcome or overall death. The main outcome combined cardiovascular death, heart attack, resuscitated cardiac arrest and hospitalisation for unstable angina or heart failure. Both groups received medical care; the comparison was not a procedure against doing nothing. The finding also had boundaries. Patients with recent acute coronary syndromes, important left-main artery disease and certain other high-risk features were excluded. It cannot be extended into an instruction to withhold emergency treatment or reject intervention in every patient with coronary disease.
Symptom relief and survival are different outcomes
A separate report from the same trial examined angina-related symptoms, function and quality of life. The initial invasive strategy produced greater average improvement in these measures. The difference was larger among people who had frequent angina at the start, with little benefit among those without angina. This was a related analysis of the same trial, not a second independent experiment. It helps explain why an intervention may offer meaningful symptom relief even when an overall survival advantage has not been demonstrated.
Extended follow-up, published online in November 2022, added further detail. Over a median of 5.7 years, overall mortality remained similar between the initial strategies. Cardiovascular mortality was lower with the invasive strategy, while non-cardiovascular mortality was higher. These findings do not support a simple claim that every outcome was identical. They also do not establish that all stable patients gain an overall survival benefit from early intervention. The outcome measured and the patients studied both matter.
Medicines, procedures and continuing care work together
For stable angina, Britain's National Institute for Health and Care Excellence recommends initial medical treatment and assessment of the response. It also provides for restoration of blood supply when symptoms remain inadequately controlled and the anatomy is suitable. The choice between PCI and coronary artery bypass grafting depends on the pattern of disease and other clinical factors. Bypass grafting creates another route for blood to reach the heart. It is not the same procedure as placing a stent within an existing artery.
A stent treats a particular segment; continuing coronary care addresses the wider disease. The United States National Heart, Lung, and Blood Institute describes treatment involving medicines, management of risk factors and appropriate lifestyle measures alongside procedures. Cholesterol, blood pressure, diabetes and smoking can all remain relevant after an intervention. Patients with a stent may also need prescribed medicines that reduce clot formation. The procedure therefore changes the care plan rather than ending the need for care.
What a clear treatment discussion should explain
Angioplasty also carries risks. The National Health Service identifies bleeding or vessel injury, contrast-related problems and uncommon serious complications among possible harms. Narrowing can recur, and a clot can obstruct a stent. The likelihood varies with the patient's condition and the procedure's circumstances. These risks must be weighed against the expected benefit and the risks of the alternatives. A useful discussion identifies whether the main aim is urgent heart-muscle protection, symptom relief, improved prognosis or a combination.
Shared decision-making means clinicians and patients considering the evidence together with the person's circumstances and priorities. NICE guidance asks for clear explanations of benefits, harms, alternatives and uncertainty. When time permits, questions and another clinical opinion can help clarify a planned recommendation. Emergency care has a different time constraint. The earlier Keralam reporting also stressed that concern about unnecessary intervention should not delay treatment for a diagnosed emergency. Good communication supports appropriate care in both settings.
Conclusion
The Keralam debate becomes more useful when it asks what benefit a particular intervention is expected to provide. Acute coronary care, relief of persistent angina and long-term prevention involve related but different decisions. Trials must be interpreted within their populations and follow-up periods. Appropriate practice combines timely emergency treatment with careful planned assessment, continuing medical care and an explanation the patient can understand. Procedure totals or a single angiogram cannot replace that clinical reasoning.